ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 127 filers reported holding ANIKA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $529,409 | -28.7% | 28,417 | -0.6% | 0.02% | -25.0% |
| Q2 2023 | $742,846 | +38.1% | 28,593 | +52.6% | 0.03% | +33.3% |
| Q1 2023 | $538,012 | -2.0% | 18,733 | +1.0% | 0.02% | -8.7% |
| Q4 2022 | $549,050 | -2.3% | 18,549 | -21.4% | 0.02% | -8.0% |
| Q3 2022 | $562,000 | +6.0% | 23,600 | -0.6% | 0.02% | +13.6% |
| Q2 2022 | $530,000 | +54.5% | 23,734 | +73.8% | 0.02% | +46.7% |
| Q1 2022 | $343,000 | -38.4% | 13,655 | -12.2% | 0.02% | -25.0% |
| Q4 2021 | $557,000 | -28.6% | 15,555 | -15.1% | 0.02% | -28.6% |
| Q3 2021 | $780,000 | -5.1% | 18,316 | -3.5% | 0.03% | 0.0% |
| Q2 2021 | $822,000 | +3.1% | 18,980 | -2.9% | 0.03% | +12.0% |
| Q1 2021 | $797,000 | -12.2% | 19,548 | -2.6% | 0.02% | -16.7% |
| Q4 2020 | $908,000 | +66.3% | 20,064 | +30.0% | 0.03% | +42.9% |
| Q3 2020 | $546,000 | -49.9% | 15,435 | -46.6% | 0.02% | -40.0% |
| Q2 2020 | $1,090,000 | +51.8% | 28,897 | +16.3% | 0.04% | +84.2% |
| Q1 2020 | $718,000 | – | 24,850 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
| Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
| DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
| Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
| Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
| CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
| Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
| BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
| XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |